Skip to main content
Log in

“Pemetrexed”

Decision of the Federal Supreme Court (Bundesgerichtshof) 14 June 2016 – Case No. X ZR 29/15

  • Decision • Patent Law
  • Germany
  • Published:
IIC - International Review of Intellectual Property and Competition Law Aims and scope Submit manuscript
  1. a)

    A patent infringement by equivalent means is as a rule to be denied if the description of the patent discloses more than one possibility of how to achieve a certain technical effect but only one of these possibilities has been included in the patent claim (confirming Federal Supreme Court, decision of 10 May 2011 – X ZR 16/09, BGHZ 189, 330 = GRUR 2011, 701 para. 35 – Okklusionsvorrichtung [42 IIC 851 (2011) – Occlusion Device, para. 35]; [further citation omitted]).

  2. b)

    For this principle to apply, it is not sufficient for an embodiment claimed by the patent to be represented, due to information in the description or other reasons, as a special application of a more general approach and for the person skilled in the art, due to this insight, to be capable of discovering other relevant embodiments of this approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Consortia

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

European Patent Convention, Art. 69(1); Protocol on the Interpretation of Article 69 EPC, Arts. 1 and 2; Patent Act, Sec. 14. “Pemetrexed”. IIC 48, 208–220 (2017). https://doi.org/10.1007/s40319-016-0532-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40319-016-0532-3

Keywords

Navigation